Summary
Kipp Akers is a bioinformatics leader with 11 years of experience translating RNA-Seq and genomic data into clinically actionable insights, now directing computational efforts at Adaptive Biotechnologies in Seattle. He blends deep academic training (PhD/MS/BS from UC Berkeley) and postdoctoral work with hands-on industry experience developing and validating DNA sequence–based in vitro diagnostics aimed at FDA approval. His work spans oncology, immunology, epidemiology and big-data computational biology, with a track record of collaborative research and publications across multiple malignancies. Known for improving detection of circRNA, fusions, and mutation calling from RNA-Seq, he brings both algorithmic rigor and practical validation expertise. Notably, he advances projects from method development through analytical and clinical validation, bridging research-grade analyses to regulated diagnostic deployment.
11 years of coding experience
9 years of employment as a software developer
Ph.D Environmental Health Sciences; Computational and Genomic Biology, Ph.D Environmental Health Sciences; Computational and Genomic Biology at University of California, Berkeley
r, perl, bash, python